CVRx (CVRX) Net Margin (2020 - 2026)

CVRx's (CVRX) quarterly Net Margin came in at 88.83% in Q1 2026, up 2265.0% year-on-year from 3.76% in Q1 2025, and down 19.28% quarter-over-quarter from 74.48% in Q4 2025.

CVRx (CVRX) Net Margin (2020 - 2026) Analysis & Trends

CVRx's Net Margin history runs 7 years deep, the most recent figure standing at 88.83% for Q1 2026.

  • On a quarterly basis, Net Margin rose 2265.0% year-over-year to 88.83% in Q1 2026; TTM through Mar 2026 was 89.15%, a 837.0% increase from a year earlier, with the FY2025 full-year figure at 94.1%, up 2284.0% from the prior year.
  • Net Margin fell to 88.83% in Q1 2026 per CVRX's latest filing, from 74.48% in the prior quarter.
  • Across five years, Net Margin topped out at 69.5% in Q4 2024 and bottomed at 245.12% in Q1 2022.
  • The 5-year median for Net Margin is 111.48% (2025), against an average of 127.33%.
  • Across the five-year window, Net Margin jumped 34824 bps in 2022 and plunged 6345 bps in 2024, its largest moves.
  • Year by year, Net Margin stood at 146.82% in 2022, then soared by 46 bps to 79.75% in 2023, then gained by 13 bps to 69.5% in 2024, then fell by 7 bps to 74.48% in 2025, then decreased by 19 bps to 88.83% in 2026.
  • Per Business Quant, the three latest CVRX Net Margin figures stand at 88.83% (Q1 2026), 74.48% (Q4 2025), and 87.61% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.65%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.38%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 12.84%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 16.74%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 8.01%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 CVRx 128.88 Mn 56.58 Mn 12.88 Mn -88.83%

Historic Data

Download Data
DateValue
Mar 31, 2026 -88.83%
Dec 31, 2025 -74.48%
Sep 30, 2025 -87.61%
Jun 30, 2025 -108.44%
Mar 31, 2025 -111.48%
Dec 31, 2024 -69.50%
Sep 30, 2024 -97.95%
Jun 30, 2024 -118.82%
Mar 31, 2024 -206.00%
Dec 31, 2023 -79.75%
Sep 30, 2023 -85.73%
Jun 30, 2023 -122.64%
Mar 31, 2023 -142.55%
Dec 31, 2022 -146.82%
Sep 30, 2022 -158.91%
Jun 30, 2022 -220.06%
Mar 31, 2022 -245.12%
Dec 31, 2021 -288.96%
Sep 30, 2021 -180.65%
Jun 30, 2021 -568.30%